PHASE II RANDOMIZED TRIAL OF OPTIMAL RECURRENCE-DIRECTED THERAPY (RDT) WITHOUT OR WITH ANDROGEN-DEPRIVATION THERAPY (ADT) IN RADIO-RECURRENT OLIGO-METASTATIC HORMONE/CASTRATE SENSITIVE PROSTATE CANCER (ROMCSPC): THE OCOG-RATIONAL-PCS TRIAL Conferences uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Gouveia, Andre
  • Vavassis, Peter
  • Mesci, Aruz
  • Hotte, Sebastien
  • Berlin, Alejandro
  • Zukotynski, Katherine
  • Morgan, Scott
  • Dayes, Ian
  • Perlis, Nathan
  • Wright, Jim
  • Pond, Gregory
  • Niazi, Tamim
  • Tsakiridis, Theodoros

publication date

  • September 2024